Biomedtracker: see the drug development process through anal...
Key Potential Drug Launches in 2022
Released July 22, 2021. Contains information like likelihood of approval (LOA) ratings and upcoming catalysts that are current as of April 2021.
As the aging population in the US, UK and Europe increases, cases of multiple have increased as well, bring new therapies and questions about the future of care. This webinar provides a comprehensive look at the disease and treatments including the new launches that are transforming clinical practice, the relative value of multiple myeloma regimens, and the evolution of the multiple myeloma market.
Beginning with the current access levers used by payers and a comparison of US and five major European markets, you’ll learn the key factors in European payers’ assessment of multiple myeloma treatments, the significant changes we are seeing in the US oncology market, and why payers have begun imposing cost-control strategies such as ICER and other value frameworks to evaluate cost-effectiveness.
Biomedtracker: see the drug development process through anal...
Released July 22, 2021. Contains information like likelihood of approval (LOA) ratings and upcoming catalysts that are current as of April 2021.
Biomedtracker: see the drug development process through anal...
Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.
Topics Drug Review Coronavirus
Datamonitor Healthcare: data analysis and insight, Biomedtra...
The American Society of Clinical Oncology (ASCO) hosted its annual meeting from June 4-8 2021 and our team has the exclusive insights and analysis you can access today.
Topics Cancer
Datamonitor Healthcare: data analysis and insight
One hundred billion dollars. That is the combined revenue of the top 10 pharmaceuticals in 2020, marking the first year in which this threshold has been crossed.
Topics Drug Review Drug Pricing
Biomedtracker: see the drug development process through anal...
The Pharma Intelligence analyst team will be covering the 2021 ASCO virtual meeting from June 4-8, 2021.
Datamonitor Healthcare: data analysis and insight
The Butterfly Effect is an elegant analogy to describe the seemingly unpredictable and far-reaching implications of a relatively small and inconsequential event.
Topics Alzheimer's Disease
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: